283 related articles for article (PubMed ID: 17030350)
21. HOXB8 expression in ovarian serous carcinoma effusions is associated with shorter survival.
Stavnes HT; Holth A; Don T; Kærn J; Vaksman O; Reich R; Trope' CG; Davidson B
Gynecol Oncol; 2013 May; 129(2):358-63. PubMed ID: 23438671
[TBL] [Abstract][Full Text] [Related]
22. Nuclear expression of survivin is associated with improved survival in metastatic ovarian carcinoma.
Kleinberg L; Flørenes VA; Silins I; Haug K; Trope CG; Nesland JM; Davidson B
Cancer; 2007 Jan; 109(2):228-38. PubMed ID: 17167759
[TBL] [Abstract][Full Text] [Related]
23. NK- and B-cell infiltration correlates with worse outcome in metastatic ovarian carcinoma.
Dong HP; Elstrand MB; Holth A; Silins I; Berner A; Trope CG; Davidson B; Risberg B
Am J Clin Pathol; 2006 Mar; 125(3):451-8. PubMed ID: 16613351
[TBL] [Abstract][Full Text] [Related]
24. Expression of the folate receptor genes FOLR1 and FOLR3 differentiates ovarian carcinoma from breast carcinoma and malignant mesothelioma in serous effusions.
Yuan Y; Nymoen DA; Dong HP; Bjørang O; Shih IeM; Low PS; Trope' CG; Davidson B
Hum Pathol; 2009 Oct; 40(10):1453-60. PubMed ID: 19454358
[TBL] [Abstract][Full Text] [Related]
25. MUC4 is upregulated in ovarian carcinoma effusions and differentiates carcinoma cells from mesothelial cells.
Davidson B; Baekelandt M; Shih IeM
Diagn Cytopathol; 2007 Dec; 35(12):756-60. PubMed ID: 18008338
[TBL] [Abstract][Full Text] [Related]
26. Class III β-tubulin expression in advanced-stage serous ovarian carcinoma effusions is associated with poor survival and primary chemoresistance.
Hetland TE; Hellesylt E; Flørenes VA; Tropé C; Davidson B; Kærn J
Hum Pathol; 2011 Jul; 42(7):1019-26. PubMed ID: 21315408
[TBL] [Abstract][Full Text] [Related]
27. Heat shock protein 90 is a putative therapeutic target in patients with recurrent advanced-stage ovarian carcinoma with serous effusions.
Elstrand MB; Stavnes HT; Tropé CG; Davidson B
Hum Pathol; 2012 Apr; 43(4):529-35. PubMed ID: 21864883
[TBL] [Abstract][Full Text] [Related]
28. Claudin upregulation in ovarian carcinoma effusions is associated with poor survival.
Kleinberg L; Holth A; Trope CG; Reich R; Davidson B
Hum Pathol; 2008 May; 39(5):747-57. PubMed ID: 18439941
[TBL] [Abstract][Full Text] [Related]
29. Expression of heparanase in renal cell carcinomas: implications for tumor invasion and prognosis.
Mikami S; Oya M; Shimoda M; Mizuno R; Ishida M; Kosaka T; Mukai M; Nakajima M; Okada Y
Clin Cancer Res; 2008 Oct; 14(19):6055-61. PubMed ID: 18809970
[TBL] [Abstract][Full Text] [Related]
30. SCARA3 mRNA is overexpressed in ovarian carcinoma compared with breast carcinoma effusions.
Bock AJ; Nymoen DA; Brenne K; Kærn J; Davidson B
Hum Pathol; 2012 May; 43(5):669-74. PubMed ID: 21855113
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of cell surface expression of phosphatidylserine in ovarian carcinoma effusions using the annexin-V/7-AAD assay: clinical relevance and comparison with other apoptosis parameters.
Dong HP; Holth A; Kleinberg L; Ruud MG; Elstrand MB; Tropé CG; Davidson B; Risberg B
Am J Clin Pathol; 2009 Nov; 132(5):756-62. PubMed ID: 19846818
[TBL] [Abstract][Full Text] [Related]
32. Kallikrein 4 is expressed in malignant mesothelioma--further evidence for the histogenetic link between mesothelial and epithelial cells.
Davidson B; Xi Z; Saatcioglu F
Diagn Cytopathol; 2007 Feb; 35(2):80-4. PubMed ID: 17230566
[TBL] [Abstract][Full Text] [Related]
33. Kallikrein 4 expression is up-regulated in epithelial ovarian carcinoma cells in effusions.
Davidson B; Xi Z; Klokk TI; Tropé CG; Dørum A; Scheistrøen M; Saatcioglu F
Am J Clin Pathol; 2005 Mar; 123(3):360-8. PubMed ID: 15716231
[TBL] [Abstract][Full Text] [Related]
34. Alphav integrin expression is a novel marker of poor prognosis in advanced-stage ovarian carcinoma.
Goldberg I; Davidson B; Reich R; Gotlieb WH; Ben-Baruch G; Bryne M; Berner A; Nesland JM; Kopolovic J
Clin Cancer Res; 2001 Dec; 7(12):4073-9. PubMed ID: 11751504
[TBL] [Abstract][Full Text] [Related]
35. The AP-2gamma transcription factor is upregulated in advanced-stage ovarian carcinoma.
Ødegaard E; Staff AC; Kaern J; Flørenes VA; Kopolovic J; Tropé CG; Abeler VM; Reich R; Davidson B
Gynecol Oncol; 2006 Mar; 100(3):462-8. PubMed ID: 16216317
[TBL] [Abstract][Full Text] [Related]
36. [The expression of acetyl-heparanase, laminin and laminin receptor and their role in the metastasis of ovarian cancer].
Liu Y; Xin XY; Han LF; Wang DT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2003 Sep; 19(5):459-61. PubMed ID: 15169656
[TBL] [Abstract][Full Text] [Related]
37. Osteopontin expression in ovarian carcinoma effusions is related to improved clinical outcome.
Davidson B; Holth A; Moripen L; Trope' CG; Shih IeM
Hum Pathol; 2011 Jul; 42(7):991-7. PubMed ID: 21315424
[TBL] [Abstract][Full Text] [Related]
38. Nucleoside transporters are widely expressed in ovarian carcinoma effusions.
Bock AJ; Dong HP; Tropé CG; Staff AC; Risberg B; Davidson B
Cancer Chemother Pharmacol; 2012 Feb; 69(2):467-75. PubMed ID: 21822668
[TBL] [Abstract][Full Text] [Related]
39. Wee1 is a novel independent prognostic marker of poor survival in post-chemotherapy ovarian carcinoma effusions.
Slipicevic A; Holth A; Hellesylt E; Tropé CG; Davidson B; Flørenes VA
Gynecol Oncol; 2014 Oct; 135(1):118-24. PubMed ID: 25093290
[TBL] [Abstract][Full Text] [Related]
40. [Relationship of cyclooxygenase 2 expression and chemotherapy response and prognosis in human ovarian carcinoma].
Lou WZ; Shen K; Zhang Y; Lang JH
Zhonghua Fu Chan Ke Za Zhi; 2004 Aug; 39(8):529-32. PubMed ID: 15363351
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]